Literature DB >> 2998417

Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome.

J Lindstrom.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998417     DOI: 10.1146/annurev.iy.03.040185.000545

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


× No keyword cloud information.
  23 in total

1.  Immunoglobulin heavy chain gene associations in myasthenia gravis: new evidence for disease heterogeneity.

Authors:  A Demaine; N Willcox; M Janer; K Welsh; J Newsom-Davis
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

Review 2.  Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators.

Authors:  E L Ochoa; A Chattopadhyay; M G McNamee
Journal:  Cell Mol Neurobiol       Date:  1989-06       Impact factor: 5.046

3.  Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the alpha subunit.

Authors:  S J Tzartos; A Kokla; S L Walgrave; B M Conti-Tronconi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

Review 4.  Specificities of autoantibodies in autoimmune receptor diseases.

Authors:  M H De Baets
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 5.  Molecular studies of the neuronal nicotinic acetylcholine receptor family.

Authors:  J Lindstrom; R Schoepfer; P Whiting
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

6.  Action of antibodies directed against the acetylcholine receptor on channel function at mouse and rat motor end-plates.

Authors:  J O Dolly; M Gwilt; G Lacey; J Newsom-Davis; A Vincent; P Whiting; D W Wray
Journal:  J Physiol       Date:  1988-05       Impact factor: 5.182

7.  Fine antigenic specificities of antibodies in sera from patients with D-penicillamine-induced myasthenia gravis.

Authors:  S J Tzartos; E Morel; A Efthimiadis; A F Bustarret; J D'Anglejan; A A Drosos; H A Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

8.  Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cells.

Authors:  Badiga Venkata Aruna; Michael Sela; Edna Mozes
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-12       Impact factor: 11.205

9.  Effects of the rate of acetylcholine receptor synthesis on the severity of experimental autoimmune myasthenia gravis.

Authors:  M H De Baets; J Verschuuren; M R Daha; P J van Breda Vriesman
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

10.  Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera.

Authors:  T Gordon; B Grove; J C Loftus; T O'Toole; R McMillan; J Lindstrom; M H Ginsberg
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.